AI assistant
Sending…
Zelluna ASA — Director's Dealing 2024
Jan 4, 2024
3779_dirs_2024-01-04_f01a90d1-8b36-494b-af13-07466039534c.pdf
Director's Dealing
Open in viewerOpens in your device viewer
K R T - 1 5 0 0 T e m pla t e f o r n o tific a tio n o f t r a n s a c tio n s b y p e r s o n s dis c h a r gin g m a n a g e rial r e s p o n sibilitie s ( PDM R ) a n d p e r s o n s clo s ely a s s o cia t e d wit h t h e m
| The person liable: | ||||
|---|---|---|---|---|
| PDMR | Closely associated person (natural Closely associated person (legal person) person) |
|||
| About PDMR | ||||
| Last name | FREITAS DE SOUS A |
|||
| First name | CARLOS | |||
| Position / role | CEO | |||
| Initial notification or amendment to prior notification | ||||
| Initial | Amendment | |||
| Details about the issuer or emission allowance market participant | ||||
| Business name | ULTIMOVACS A S A |
|||
| LEI number | 254900B4VALJZR9TL744 |
Skjema versjon: 46345
K R T - 1 5 0 0 T e m pla t e f o r n o tific a tio n o f t r a n s a c tio n s b y p e r s o n s dis c h a r gin g m a n a g e rial r e s p o n sibilitie s ( PDM R ) a n d p e r s o n s clo s ely a s s o cia t e d wit h t h e m
1/4/2024 2:41:16 PM AR591289366
| Description of the financial instrument/type of instrument | ||||
|---|---|---|---|---|
| Instrument | Share | |||
| ISIN code | NO0010851603 | |||
| Name of the financial instrument | ||||
| Nature of the transaction | ||||
| Transaction type | Acquisition | |||
| Share option program | ||||
| The transaction is linked to an excersise of a share option program Yes No |
||||
| Currency of the transaction | ||||
| Currency | NOK | |||
| Price(s) and volume(s) | ||||
| Price per unit | 130 | |||
| Volume | 500 | |||
| Aggregated information | ||||
| Average price per unit | 130.00000 | |||
| Aggregated volume | 500 | |||
| Total amount | 65 000.000000 | |||
| Date of the transaction | ||||
| Date | 1/4/2024 | |||
| Place of the transaction | ||||
| Trading venue | XOSL - Oslo Børs | |||
Comment
More from Zelluna ASA
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Investor Presentation
2026
May 4
AGM Information
2026
Apr 23
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 23
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 8